These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16619573)

  • 41. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
    Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
    Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant messenger RNA splicing of the cytokeratin 8 in lung cancer.
    Tojo Y; Bandoh S; Fujita J; Kubo A; Ishii T; Fukunaga Y; Ueda Y; Yang Y; Wu F; Huang CL; Yokomise H; Ishida T
    Lung Cancer; 2003 Nov; 42(2):153-61. PubMed ID: 14568682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of circulating tumor cells in peripheral blood of breast cancer patients during or after therapy using a multigene real-time RT-PCR assay.
    Zehentner BK; Secrist H; Hayes DC; Zhang X; Ostenson RC; Loop S; Goodman G; Houghton RL; Persing DH
    Mol Diagn Ther; 2006; 10(1):41-7. PubMed ID: 16646576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Research progress of circulating tumor DNA methylation in non-small cell lung cancer].
    Yang Lan L; Chen Bojiang BJ; Li Lei L
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):967-970. PubMed ID: 30522195
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
    Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
    Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer].
    Zhang Y; Xu Y; Wang M
    Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):766-772. PubMed ID: 27866520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection?
    Schmidt B; Engel E; Carstensen T; Weickmann S; John M; Witt C; Fleischhacker M
    Lung Cancer; 2005 Apr; 48(1):145-7. PubMed ID: 15777983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of RT-PCR to detect co-expression of neuropeptides and their receptors in lung cancer.
    Ocejo-Garcia M; Ahmed SI; Coulson JM; Woll PJ
    Lung Cancer; 2001 Jul; 33(1):1-9. PubMed ID: 11429190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.
    Katz RL; He W; Khanna A; Fernandez RL; Zaidi TM; Krebs M; Caraway NP; Zhang HZ; Jiang F; Spitz MR; Blowers DP; Jimenez CA; Mehran RJ; Swisher SG; Roth JA; Morris JS; Etzel CJ; El-Zein R
    Clin Cancer Res; 2010 Aug; 16(15):3976-87. PubMed ID: 20651054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method.
    Sawabata N; Okumura M; Utsumi T; Inoue M; Shiono H; Minami M; Nishida T; Sawa Y
    Gen Thorac Cardiovasc Surg; 2007 May; 55(5):189-92. PubMed ID: 17554991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
    Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma.
    Saintigny P; Coulon S; Kambouchner M; Ricci S; Martinot E; Danel C; Breau JL; Bernaudin JF
    Int J Cancer; 2005 Jul; 115(5):777-82. PubMed ID: 15729695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
    Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
    J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer.
    Allan JM; Hardie LJ; Briggs JA; Davidson LA; Watson JP; Pearson SB; Muers MF; Wild CP
    Int J Cancer; 2001 Feb; 91(3):359-65. PubMed ID: 11169960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges.
    Matikas A; Syrigos KN; Agelaki S
    Clin Lung Cancer; 2016 Nov; 17(6):507-516. PubMed ID: 27373516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.